Comments

Allogene Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Allogene Therapeutics (ALLO) operate in?

Allogene Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ALLONASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Q1 2025 Earnings were released on Tue May 13th, after the market close

The most recent conference call was at 17:00 PM, 2 days ago Click to view past webcast

Allogene Therapeutics (ALLO) Forecast

News Earnings Allogene Therapeutics (ALLO) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Allogene Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:ALLO | Benzinga

Explore Allogene Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ALLO.

Open	$0.95
Close	-
Volume / Avg.	1.77M / 5.84M
Day Range	$0.94 - $1.08
52 Wk Range	0.86 - 3.78
Market Cap	$218.35M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	30
Short Interest	19.22%
Days to Cover	13.41

Recent News

Watsco Posts Upbeat Results, Joins GeneDx, Intel And Other Big Stocks Moving Higher On Tuesday

Avi Kapoor

Cell Therapy Mostly Used For Blood Cancer Shows Efficacy In Autoimmune Diseases As Well, But There Are Challenges

CAR-T therapy, originally used for blood cancers, shows promising results in treating lupus, as evidenced by Janina Paech's remarkable remission. This breakthrough offers new hope for autoimmune disease patients but faces challenges in cost and manufacturing.

Vandana Singh

Why James Hardie Industries Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.95
Close	-
Volume / Avg.	1.77M / 5.84M
Day Range	$0.94 - $1.08
52 Wk Range	0.86 - 3.78
Market Cap	$218.35M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	30
Short Interest	19.22%
Days to Cover	13.41

About Allogene Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing...

Got Questions? Ask

Analyze ALLO's financials

How has ALLO's EPS changed?

How is ALLO's EV/EBITDA ratio?

What are analysts' targets for ALLO?

What is ALLO's P/E ratio?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Allogene Therapeutics (ALLO) stock?

You can purchase shares of Allogene Therapeutics (NASDAQ:ALLO) through any online brokerage.

View our list of the best stock brokerages

Who are Allogene Therapeutics (ALLO) competitors?

Other companies in Allogene Therapeutics’s space includes: Innate Pharma (NASDAQ:IPHA), CytomX Therapeutics (NASDAQ:CTMX), Monopar Therapeutics (NASDAQ:MNPR), Tevogen Bio Holdings (NASDAQ:TVGN) and TransCode Therapeutics (NASDAQ:RNAZ).

What is the forecast, or price target, for Allogene Therapeutics (ALLO) stock?

Allogene Therapeutics has a consensus price target of $12.03.

What is the current price for Allogene Therapeutics (ALLO)?

The stock price for Allogene Therapeutics (NASDAQ: ALLO) is $1.005 last updated May 15, 2025 at 11:44 AM EDT.

Does Allogene Therapeutics (ALLO) pay a dividend?

There are no upcoming dividends for Allogene Therapeutics.

When is Allogene Therapeutics (NASDAQ:ALLO) reporting earnings?

Allogene Therapeutics’s Q2 earnings are confirmed for Wednesday, August 6, 2025.

Is Allogene Therapeutics (ALLO) going to split?

There is no upcoming split for Allogene Therapeutics.

What sector and industry does Allogene Therapeutics (ALLO) operate in?

Allogene Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.